Trailing Twelve Months Revenue Growth: Monopar Corp (MNPR)

Public company logo of monopartx.com (MNPR)

Monopar Therapeutics (MNPR) focuses on the B2B segment, developing tools to minimize chemotherapy side effects in clinics. The year-over-year (12-month) relative revenue growth rate reflects the development trend, with the indicator standing at 0.00. US centers that reduce treatment toxicity ensure the business's stability. The company is currently moving its promising radiopharmaceutical pipeline and targeted drugs into the early clinical testing stage.

Monopar Therapeutics (MNPR): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Monopar Therapeutics - analytical breakdowns and key metrics (MNPR)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Monopar Pharma
Brand item of Monopar Corp

This indicator measures the revenue growth rate over a rolling year, smoothing out short-term anomalies to assess the actual operational resilience of the business. For Monopar Therapeutics (MNPR), which focuses on radiopharmaceutical R&D, the TTM revenue growth rate serves as a marker for the transition from pure funding to the commercialization of innovations, where a lack of growth coupled with high research expenditures signals high risks for capital.

Who Monopar Therapeutics competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Inhibrx Biosciences Inc INBX|Revenue Growth YoY (Last 12 Months) IMAB|Trailing Twelve Months Revenue Growth Fennec Pharmaceuticals FENC|Revenue Growth YoY (Last 12 Months) HRTX (Heron)|NVCT (Nuvectis Pharma) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)